This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Noviasky, J. A. Articles by Lee, Y. H. Search for Related Content PubMed Articles by Noviasky, J. A. Articles by Lee, Y. H. Social Bookmarking                   What's this?

Second Generation Anticonvulsant Medications: Their Use in Children

John A. Noviasky, PharmD, is the clinical pharmacy coordinator at St. Elizabeth Medical Center in Utica, NY, and a clinical instructor in the Department of Pharmacy Practice at the University at Buffalo, NY

Anton P. Porsteinsson, MD

Anton P. Porsteinsson, MD, is an assistant professor of psychiatry at the University of Rochester Medical Center, Monroe Community Hospital, Rochester, NY

Yeong H. Lee, MD

Yeong H. Lee, MD, has been certified in pediatrics since 1978. He is in full-time private practice and on staff at United Memorial Medical Center in Batavia, NY

The pharmacotherapy of seizure disorders has long relied on a few standard medications such as phenobarbital, phenytoin (Dilantin), valproate (Depakote), and others that represent the "first generation" of anticonvulsants. This article reviews the newer, "second-generation" anticonvulsants that were developed in the last decade. The addition of these second-generation agents has doubled the number of therapies available for the treatment of seizure disorders. They include felbamate (Felbatol), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), tiagabine (Gabitril), topiramate (Topamax), and zonisamide (Zonegran). This article describes the known side effects of the second-generation agents and reviews the adverse reactions of the first generation of anticonvulsants as a guide to potential toxicities. Reference tables are included that note usual dosages, available dosage forms, and tablet imprint. In addition, this article describes monitoring parameters and gives specific information regarding the use of these agents.

Key Words: first-generation anticonvulsants • second-generation anticonvulsants • seizure disorders • toxicity

The Journal of School Nursing, Vol. 17, No. 2, 103-111 (2001)
DOI: 10.1177/105984050101700208


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?